Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
about
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer modelsRenal cell carcinoma.Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.The therapeutic potential of HIF-2 antagonism in renal cell carcinoma.Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
P2860
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@en
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@nl
type
label
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@en
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@nl
prefLabel
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@en
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Whole-Exome Sequencing in Two ...... ear Cell Renal Cell Carcinoma.
@en
P2093
A Ari Hakimi
Andre P Fay
Bradley Murray
David F McDermott
David J Kwiatkowski
Eliezer M Van Allen
Joaquim Bellmunt
Laurence Albiges
Melissa L Stanton
Michael B Atkins
P2860
P304
P356
10.6004/JNCCN.2016.0086
P577
2016-07-01T00:00:00Z